Clinical Trial Update: Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) for autoimmune pulmonary alveolar proteinosis; the curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Pulmonary Alveolar Proteinosis

Drugs mentioned

• GM-CSF inhalation (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Autoimmune Pulmonary Alveolar Proteinosis | Phase 2 | Status: UNKNOWN